Inventor · disambiguated record
Richie Khanna
Also filed as: KHANNA RICHIE
14 granted patents·4 pending applications·203 citations·filing 2010–2025
93Inventor score
Top patents by PatentIndex Score
18 records- 0196US11278601B2Augmented acid alpha-glucosidase for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2020·Granted Mar 22, 2022·5 cites·13 claims
- 0296US10357548B2α-galactosidase A and 1-deoxygalactonojirimycin co-formulationAMICUS THERAPEUTICS INC·Filed 2017·Granted Jul 23, 2019·49 cites·18 claims
- 0396US10155027B2Alpha-galactosidase A and 1-deoxygalactonojirimycin co-formulation for the treatment of fabry diseaseAMICUS THERAPEUTICS INC·Filed 2017·Granted Dec 18, 2018·49 cites·19 claims
- 0495US10857212B2Augmented acid alpha-glucosidase for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Dec 8, 2020·7 cites·31 claims
- 0595US9694056B2α-galactosidase A and 1-deoxygalactonojirimycin co-formulationAMICUS THERAPEUTICS INC·Filed 2013·Granted Jul 4, 2017·50 cites·16 claims
- 0692US9404100B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2013·Granted Aug 2, 2016·16 cites·20 claims
- 0792US9303249B2High concentration α-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·15 cites·18 claims
- 0887US10512677B2High concentration alpha-glucosidase compositions for the treatment of pompe diseaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·4 cites·15 claims
- 0987US10046033B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2016·Granted Aug 14, 2018·4 cites·20 claims
- 1081US12419937B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2022·Granted Sep 23, 2025·0 cites·18 claims
- 1180US12414985B2Augmented acid alpha-glucosidase for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2022·Granted Sep 16, 2025·0 cites·33 claims
- 1277US12246062B2Recombinant human acid alpha-glucosidaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Mar 11, 2025·1 cites·19 claims
- 1376US2025057925A1Recombinant Human Acid Alpha-GlucosidaseAMICUS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1474US2025381254A1Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe DiseaseAMICUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1571US11278599B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2019·Granted Mar 22, 2022·0 cites·20 claims
- 1666US2017189497A1Augmented Acid Alpha-Glucosidase For The Treatment Of Pompe DiseaseAMICUS THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1763US8466340B2Mouse model for pompe disease and methods of use thereofKHANNA RICHIE·Filed 2010·Granted Jun 18, 2013·3 cites·11 claims
- 1860US2025161483A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxiaLEXEO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richie Khanna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →